Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Genet ; 88(5): 450-5, 2015 Nov.
Article in English | MEDLINE | ID: mdl-25318593

ABSTRACT

Type of cancer and age of onset in individuals with inherited aberrations in the tumour suppressor gene TP53 are variable, possibly influenced by genetic modifiers and different environmental exposure. Since 2009, the modified Chompret criteria (MCC) have been used to identify individuals for TP53 mutation screening. Using the TP53 mutation database maintained by the International Agency for Research on Cancer (IARC), we investigated if the MCC, mainly developed for a Caucasian population, was also applicable in Asia. We identified several differences in Asian families compared with similar Caucasian cohorts, suggesting that identification and management of Li-Fraumeni syndrome in Asia do not completely mirror that of North America and Western Europe. Early gastric cancer (<40 years) may be considered a new addition to the MCC especially for Asian families.


Subject(s)
Li-Fraumeni Syndrome/complications , Mutation , Stomach Neoplasms/epidemiology , Tumor Suppressor Protein p53/genetics , Asian People/genetics , Humans , Stomach Neoplasms/genetics
2.
Med J Malaysia ; 66(2): 156-7, 2011 Jun.
Article in English | MEDLINE | ID: mdl-22106703

ABSTRACT

Trilateral retinoblastoma is the association of hereditary bilateral or unilateral retinoblastoma with a pineal neuroblastic tumour. We describe two cases of trilateral retinoblastoma from a total of 141 cases of retinoblastoma seen over an 8.5 year period. Both had a fatal outcome, with survival times of only 4 and 8 months respectively.


Subject(s)
Retinal Neoplasms/diagnosis , Retinal Neoplasms/therapy , Retinoblastoma/diagnosis , Retinoblastoma/therapy , Child, Preschool , Fatal Outcome , Female , Humans , Infant , Male , Retinal Neoplasms/etiology , Retinoblastoma/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...